Ultimovacs ASA (OSL:ULTI) Other Stockholders Equity : kr60.70 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Ultimovacs ASA Other Stockholders Equity?

Ultimovacs ASA's Other Stockholders Equity for the quarter that ended in Dec. 2023 was kr60.70 Mil.

Ultimovacs ASA's quarterly Other Stockholders Equity increased from Jun. 2023 (kr53.02 Mil) to Sep. 2023 (kr54.04 Mil) and increased from Sep. 2023 (kr54.04 Mil) to Dec. 2023 (kr60.70 Mil).

Ultimovacs ASA's annual Other Stockholders Equity increased from Dec. 2021 (kr23.21 Mil) to Dec. 2022 (kr41.72 Mil) and increased from Dec. 2022 (kr41.72 Mil) to Dec. 2023 (kr60.70 Mil).

Ultimovacs ASA Other Stockholders Equity Historical Data

The historical data trend for Ultimovacs ASA's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Other Stockholders Equity Chart

Ultimovacs ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

4.20

15.57

23.21

41.72

60.70

Ultimovacs ASA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial															41.72	49.63	53.02	54.04	60.70

Ultimovacs ASA Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Ultimovacs ASA Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ultimovacs ASA (OSL:ULTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (OSL:ULTI) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ULTIo:Sweden 7UM:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.ultimovacs.com

Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.